Fiber and the Risk of Flaring in Patients With Inflammatory Bowel Diseases: Lessons From the Crohn's and Colitis Foundation of America Database.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

2 citing papers in PubMed.

1. Sex-Specific Differences in the Gut Microbiome in Response to Dietary Fiber Supplementation in IL-10-Deficient Mice.Nutrients · 2020
   Article
2. Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance.World journal of gastroenterology · 2018
   Review

Corrections and comments

• Comment on
  Avoidance of Fiber Is Associated With Greater Risk of Crohn's Disease Flare in a 6-Month Period.2016

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as